Product image of Micafungine Viatris (Micafungin) supplied by GNH India

Micafungine Viatris

Active Ingredient:
Micafungin
Origin:
EU

Micafungine Viatris (Micafungin)

Micafungin, the active ingredient in Micafungine Viatris, is an echinocandin presented as an intravenous solution for intravenous use. It is employed to treat serious Candida infections, including bloodstream and intra‑abdominal disease, and is used for prophylaxis in high‑risk transplant patients.

GNH India supplies Micafungine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Micafungine Viatris is an echinocandin antifungal indicated for several invasive Candida infections.

  • Candidemia: rapid clearance of Candida species from the bloodstream.
  • Intra‑abdominal infections (peritonitis, intra‑abdominal abscesses): eradication of Candida from the peritoneal cavity.
  • Esophageal candidiasis: resolution of mucosal lesions and symptom relief.
  • Prophylaxis of Candida infections in hematopoietic stem cell transplantation: prevention of invasive candidiasis in immunocompromised patients.

How It Works

  • Micafungin inhibits the enzyme β‑(1,3)‑D‑glucan synthase, which is essential for synthesizing β‑(1,3)‑D‑glucan, a critical component of the fungal cell wall. Disruption of cell‑wall assembly leads to osmotic instability, cell lysis, and death of susceptible Candida species.

Side Effects

Micafungine Viatris may be associated with a range of adverse reactions.

Common Side Effects

  • Elevated liver enzymes: transient increase in ALT or AST.
  • Fever: mild to moderate temperature rise.
  • Nausea: occasional gastrointestinal discomfort.
  • Headache: mild, self‑limiting.

Serious or Rare Side Effects

  • Hepatotoxicity: significant liver injury requiring monitoring.
  • Severe hypersensitivity: rash, angioedema, or anaphylaxis.
  • Infusion‑related reactions: hypotension or bronchospasm.
  • Renal impairment: rare acute kidney injury.

Precautions & Warnings

Before initiating Micafungine Viatris, clinicians should consider several safety aspects.

  • Liver function: assess baseline enzymes and monitor during therapy.
  • Renal function: evaluate creatinine clearance, especially in patients with pre‑existing kidney disease.
  • Drug interactions: review concomitant medications that affect hepatic metabolism.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk.
  • Pediatric use: safety and efficacy not established; reserve for specific indications.
  • Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Micafungine Viatris can interact with other agents that influence its metabolism or increase toxicity.

Major Interactions (Avoid)

  • Cyclosporine: may increase micafungin exposure, raising risk of hepatotoxicity.
  • Rifampin: can reduce micafungin plasma levels, compromising efficacy.

Moderate Interactions (Monitor Closely)

  • Azole antifungals (e.g., fluconazole): may alter hepatic enzyme activity; monitor liver tests.
  • Statins (e.g., simvastatin): potential for increased statin concentrations; assess for myopathy.
  • Immunosuppressants (e.g., tacrolimus): monitor drug levels due to possible pharmacokinetic changes.

Frequently Asked Questions

Micafungine Viatris is indicated for serious Candida infections such as bloodstream (candidemia) and intra‑abdominal infections, esophageal candidiasis, and for prophylaxis of invasive candidiasis in patients undergoing hematopoietic stem cell transplantation.

Micafungin blocks the enzyme β‑(1,3)‑D‑glucan synthase, preventing the formation of β‑(1,3)‑D‑glucan, an essential structural component of the fungal cell wall. This disruption weakens the wall, causing osmotic instability, cell lysis, and death of susceptible fungi.

The dosage of Micafungine Viatris is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and treatment guidelines. Dosing regimens are individualized and should follow the prescriber’s order.

Safety data for micafungin in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To request Micafungine Viatris, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Micafungine Viatris belongs to the echinocandin class, which targets the fungal cell wall, unlike azoles that inhibit ergosterol synthesis. Echinocandins generally have a favorable safety profile and are effective against many Candida species, including some azole‑resistant strains, making them a valuable alternative for invasive infections.

Micafungine Viatris should be stored at 2‑8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution to maintain stability.

Micafungine Viatris is supplied as an intravenous solution and is administered by slow infusion into a vein, typically over 30‑60 minutes, under the supervision of qualified healthcare professionals.

Serious risks include hepatotoxicity, severe hypersensitivity reactions such as anaphylaxis, and rare infusion‑related events like hypotension or bronchospasm. Patients should be monitored for signs of liver dysfunction and allergic responses during therapy.

Micafungine Viatris is contraindicated in patients with known hypersensitivity to micafungin or any component of the formulation. Caution is also advised for individuals with severe liver impairment or those receiving interacting medications that cannot be safely managed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Micafungin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT